Literature DB >> 23093209

Cell uptake survey of pegylated nanographene oxide.

M Vila1, M T Portolés, P A A P Marques, M J Feito, M C Matesanz, C Ramírez-Santillán, G Gonçalves, S M A Cruz, A Nieto, M Vallet-Regi.   

Abstract

Graphene and more specifically, nanographene oxide (GO) has been proposed as a highly efficient antitumoral therapy agent. Nevertheless, its cell uptake kinetics, its influence in different types of cells and the possibility of controlling cellular internalization timing, is still a field that remains unexplored. Herein, different cell types have been cultured in vitro for several incubation periods in the presence of 0.075 mg ml(-1) pegylated GO solutions. GO uptake kinetics revealed differences in the agent's uptake amount and speed as a function of the type of cell involved. Osteoblast-like cells GO uptake is higher and faster without resulting in greater cell membrane damage. Moreover, the dependence on the commonly used PEG nature (number of branches) also influences the viability and cell uptake speed. These facts play an important role in the future definition of timing parameters and selective cell uptake control in order to achieve an effective therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23093209     DOI: 10.1088/0957-4484/23/46/465103

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  7 in total

Review 1.  Current Approaches and Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials.

Authors:  Wells Utembe; Harvey Clewell; Natasha Sanabria; Philip Doganis; Mary Gulumian
Journal:  Nanomaterials (Basel)       Date:  2020-06-29       Impact factor: 5.076

2.  Extending the application of a magnetic PEG three-part drug release device on a graphene substrate for the removal of Gram-positive and Gram-negative bacteria and cancerous and pathologic cells.

Authors:  M Ramezani Farani; P Khadive Parsi; Gh Riazi; M Shafiee Ardestani; H Saligeh Rad
Journal:  Drug Des Devel Ther       Date:  2019-05-10       Impact factor: 4.162

3.  The systemic effect of PEG-nGO-induced oxidative stress in vivo in a rodent model.

Authors:  Qura Tul Ain; Samina Hyder Haq; Abeer Alshammari; Moudhi Abdullah Al-Mutlaq; Muhammad Naeem Anjum
Journal:  Beilstein J Nanotechnol       Date:  2019-04-18       Impact factor: 3.649

4.  Interaction of Graphene Oxide Modified with Linear and Branched PEG with Monocytes Isolated from Human Blood.

Authors:  Pavel Khramtsov; Maria Bochkova; Valeria Timganova; Anton Nechaev; Sofya Uzhviyuk; Kseniya Shardina; Irina Maslennikova; Mikhail Rayev; Svetlana Zamorina
Journal:  Nanomaterials (Basel)       Date:  2021-12-30       Impact factor: 5.076

5.  Graphene-based phenformin carriers for cancer cell treatment: a comparative study between oxidized and pegylated pristine graphene in human cells and zebrafish.

Authors:  Abdelnour Alhourani; Jan-Lukas Førde; Mojdeh Nasrollahzadeh; Lutz Andreas Eichacker; Lars Herfindal; Hanne Røland Hagland
Journal:  Nanoscale Adv       Date:  2022-02-09

6.  Preparation and tumor cell model based biobehavioral evaluation of the nanocarrier system using partially reduced graphene oxide functionalized by surfactant.

Authors:  Yimin Wang; Kunping Liu; Zewei Luo; Yixiang Duan
Journal:  Int J Nanomedicine       Date:  2015-07-20

7.  Screening of mRNA Chemical Modification to Maximize Protein Expression with Reduced Immunogenicity.

Authors:  Satoshi Uchida; Kazunori Kataoka; Keiji Itaka
Journal:  Pharmaceutics       Date:  2015-07-23       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.